Ascletis Pharma Inc (2VJ) — Tangible Net Worth Ratio
Ascletis Pharma Inc (2VJ) has a Tangible Net Worth Ratio of 99.5% as of December 2025. This metric is calculated by deducting intangible assets (€10.29 Million) from net assets (€1.93 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Ascletis Pharma Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Ascletis Pharma Inc Tangible Net Worth Ratio (2016–2025)
This chart shows how Ascletis Pharma Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 99.5%, reflecting net assets of €1.93 Billion with intangible assets of €10.29 Million EUR. For live market cap and overall valuation, see Ascletis Pharma Inc market cap and net worth.
Annual Tangible Net Worth Ratio for Ascletis Pharma Inc (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Ascletis Pharma Inc from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Ascletis Pharma Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.5% | €1.93 Billion | €10.29 Million | €2.07 Billion | ▲ +0.1 pp |
| 2024 | 99.4% | €1.97 Billion | €12.12 Million | €2.12 Billion | ▲ +0.5 pp |
| 2023 | 98.9% | €2.34 Billion | €26.32 Million | €2.49 Billion | ▼ -0.5 pp |
| 2022 | 99.3% | €2.54 Billion | €16.56 Million | €2.66 Billion | ▲ +2.2 pp |
| 2021 | 97.1% | €2.73 Billion | €78.21 Million | €2.83 Billion | ▲ +0.2 pp |
| 2020 | 97.0% | €2.98 Billion | €90.70 Million | €3.07 Billion | ▼ -0.8 pp |
| 2019 | 97.7% | €3.32 Billion | €75.61 Million | €3.43 Billion | ▼ -0.1 pp |
| 2018 | 97.8% | €3.43 Billion | €75.40 Million | €3.53 Billion | ▲ +2.0 pp |
| 2017 | 95.8% | €869.83 Million | €36.52 Million | €991.25 Million | ▲ +0.8 pp |
| 2016 | 95.0% | €409.08 Million | €20.43 Million | €536.26 Million | — |